Buğra Çetin
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Buğra Çetin has a total of 28 co-authors. Here are the top co-authors by number of shared publications:
- Seda Gulec Yilmaz
Department of Medical Biology, Faculty of Medicine, Yeditepe University, Istanbul, Turkey
4 shared publications - Hüseyin Güleç
Department of Psychiatry, University of Health Sciences Erenköy Mental Health and Neurological Diseases Training and Research Hospital, Istanbul, Turkey
3 shared publications - Turgay Isbir
Department of Molecular Medicine, Institute of Health Science, Yeditepe University, Istanbul 34755, Türkiye
3 shared publications Hande Atasoy
2 shared publications- Hüseyin Selvi̇
Department of Medical Education, Faculty of Medicine, Mersin University, Mersin, Türkiye
2 shared publications - Uzay Gormus
Department of Biochemistry, İstanbul Bilim University, Istanbul, Turkey
2 shared publications
Latest Publications
- 24 March 2023
- Published by Cyprus Mental Health Organization in Cyprus Turkish Journal of Psychiatry and Psychology
- Vol. 5 (1) , 44-49
Socio-Demographic and Clinical Characteristics of Patients Undergoing Electroconvulsive Therapy in a Foundation University Hospital Psychiatry Clinic
Despite all studies that support its effectiveness and reliability, electroconvulsive therapy (ECT) use varies greatly both between countries and between clinics in the same countries. In this study, we aimed to investigate the frequency of ECT use, the diagnosis and socio-demographic characteristics of ECT patients, and the effect of ECT use on the clinic in patients receiving inpatient treatment at our psychiatry clinic. The study sample consist of 266 patients who received inpatient treatment at Maltepe University Medical Faculty Hospital Psychiatry Clinic, between January 1, 2017 and July 15, 2019. The data were obtained by scanning the patient files retrospectively. Between the specified dates, 61 (22.9%) of 266 patients who had been hospitalized in our clinic received ECT. 40 of these patients were female (65.6%) and 21 were male (34.4%). 25 of the patients undergoing ECT were diagnosed with depression (41.0%), 19 (31.1%) with psychotic disorder, and 17 (27.9%) with bipolar disorder. 28 (45.9%) of these patients were married, 21 (34.4%) were single, 12 (19.7%) were widowed / divorced, 13 (21.3%) were working, 38 (62.3%) 7 (11.5%) were retired and 3 (4.9%) were students. Patients who received ECT had a longer duration of hospitalization compared to patients without ECT (ECT (+) : 20 (10-33) day, ECT (-): 10 (1-54) day, p<0.001). ECT use rate was found to be 22.9% in approximately 1.5 years in the patients hospitalized in our clinic. It has been determined that ECT use rates are higher in female patients, patients with depression and non-working patients, and patients with ECT have longer hospital stay.
- 24 March 2023
- Published by Cyprus Mental Health Organization in Cyprus Turkish Journal of Psychiatry and Psychology
- Vol. 5 (1) , 44-49
Socio-Demographic and Clinical Characteristics of Patients Undergoing Electroconvulsive Therapy in a Foundation University Hospital Psychiatry Clinic
Despite all studies that support its effectiveness and reliability, electroconvulsive therapy (ECT) use varies greatly both between countries and between clinics in the same countries. In this study, we aimed to investigate the frequency of ECT use, the diagnosis and socio-demographic characteristics of ECT patients, and the effect of ECT use on the clinic in patients receiving inpatient treatment at our psychiatry clinic. The study sample consist of 266 patients who received inpatient treatment at Maltepe University Medical Faculty Hospital Psychiatry Clinic, between January 1, 2017 and July 15, 2019. The data were obtained by scanning the patient files retrospectively. Between the specified dates, 61 (22.9%) of 266 patients who had been hospitalized in our clinic received ECT. 40 of these patients were female (65.6%) and 21 were male (34.4%). 25 of the patients undergoing ECT were diagnosed with depression (41.0%), 19 (31.1%) with psychotic disorder, and 17 (27.9%) with bipolar disorder. 28 (45.9%) of these patients were married, 21 (34.4%) were single, 12 (19.7%) were widowed / divorced, 13 (21.3%) were working, 38 (62.3%) 7 (11.5%) were retired and 3 (4.9%) were students. Patients who received ECT had a longer duration of hospitalization compared to patients without ECT (ECT (+) : 20 (10-33) day, ECT (-): 10 (1-54) day, p<0.001). ECT use rate was found to be 22.9% in approximately 1.5 years in the patients hospitalized in our clinic. It has been determined that ECT use rates are higher in female patients, patients with depression and non-working patients, and patients with ECT have longer hospital stay.
- 25 February 2020
- Published by Springer Nature in Sleep and Breathing
- Vol. 24 (4) , 1591-1598
Comparison of sleep structure in patients with fibromyalgia and healthy controls
Background Sleep disturbances such as nonrestorative sleep and nighttime awakenings play a crucial role in fibromyalgia (FMS). Pain and sleep disturbances show a bidirectional relationship which affect outcomes in FMS. This study aims to compare sleep structures between patients with fibromyalgia and healthy controls. Methods We evaluated subjective and objective sleep structures of 33 patients with fibromyalgia and 34 healthy controls using the Pittsburgh Sleep Quality Index, Epworth Sleepiness Scale, and polysomnography. Student’s T test, chi-square, discriminant analysis, the Kruskal-Wallis, and Mann-Whitney U test were used for statistical analysis. Results Patients with FMS reported poorer sleep quality than controls (p = 0.003). Polysomnography data showed patients with FMS exhibited a greater number of awakenings (p = 0.01), more arousals (p = 0.00), higher arousal index (p = 0.00), greater apnea hypopnea index (p = 0.03), and less N1 sleep (p = 0.02) than healthy controls. The discriminant analysis revealed that number of arousals, arousal index, and N1 sleep were able to distinguish patients with FMS from healthy controls with 78.5% accuracy. Twelve of the 33 patients with FMS were diagnosed with obstructive sleep apnea syndrome (OSAS). When we excluded patients with OSAS, a statistically significant difference was maintained. Conclusions Our findings may explain the deterioration of subjective sleep, symptoms as unrefreshing sleep, fatigue, and pain in patients with FMS. Despite similar clinical manifestations, patients with FMS should be evaluated for OSAS due to treatment differences. The role of sleep alterations in the clinical manifestation and severity of FMS suggest that effective treatments to improve sleep quality may lead to more effective management of FMS.
- 25 February 2020
- Published by Springer Nature in Sleep and Breathing
- Vol. 24 (4) , 1591-1598
Comparison of sleep structure in patients with fibromyalgia and healthy controls
Background Sleep disturbances such as nonrestorative sleep and nighttime awakenings play a crucial role in fibromyalgia (FMS). Pain and sleep disturbances show a bidirectional relationship which affect outcomes in FMS. This study aims to compare sleep structures between patients with fibromyalgia and healthy controls. Methods We evaluated subjective and objective sleep structures of 33 patients with fibromyalgia and 34 healthy controls using the Pittsburgh Sleep Quality Index, Epworth Sleepiness Scale, and polysomnography. Student’s T test, chi-square, discriminant analysis, the Kruskal-Wallis, and Mann-Whitney U test were used for statistical analysis. Results Patients with FMS reported poorer sleep quality than controls (p = 0.003). Polysomnography data showed patients with FMS exhibited a greater number of awakenings (p = 0.01), more arousals (p = 0.00), higher arousal index (p = 0.00), greater apnea hypopnea index (p = 0.03), and less N1 sleep (p = 0.02) than healthy controls. The discriminant analysis revealed that number of arousals, arousal index, and N1 sleep were able to distinguish patients with FMS from healthy controls with 78.5% accuracy. Twelve of the 33 patients with FMS were diagnosed with obstructive sleep apnea syndrome (OSAS). When we excluded patients with OSAS, a statistically significant difference was maintained. Conclusions Our findings may explain the deterioration of subjective sleep, symptoms as unrefreshing sleep, fatigue, and pain in patients with FMS. Despite similar clinical manifestations, patients with FMS should be evaluated for OSAS due to treatment differences. The role of sleep alterations in the clinical manifestation and severity of FMS suggest that effective treatments to improve sleep quality may lead to more effective management of FMS.
- 10 June 2018
- Published by Taylor & Francis in Nordic Journal of Psychiatry
- Vol. 72 (7) , 477-483
Association between apolipoprotein E genotypes and panic disorder in Turkish population
Aim: In this study, we aimed to investigate possible interactions among the apolipoprotein E (ApoE) and panic disorder (PD), taking into account serum cholesterol levels and subfractions. Methods: ApoE genotyping was performed by real-time polymerase chain reaction in DNA samples of PD patient group (n = 45) and healthy control group (n = 50). The serum lipid levels, low-density lipoprotein (LDL), and high-density lipoprotein (HDL) subfraction analysis were examined. Results: There was a significant difference of ApoE genotypes in patient and control groups. The E3/E3 genotypes lower whereas E4 allele carriers were significantly higher in PD group ApoE4allele carriers had 3.2-fold higher risk of PD. PD group had significantly lower LDL and HDL levels. In spite of the decreased levels of total LDL, antiatherogenic large LDL subgroup was significantly lower in a patient with PD. Antiatherogenic large HDL and Intermediate HDL levels were lower, while atherogenic small HDL subfraction was significantly higher in PD group. Furthermore, Apo E3/E3 genotype carriers had significantly higher large LDL, HDL, large HDL, intermediate HDL level, and also had highest HDL between all the groups. ApoE4 allele carriers while they had highest atherogenic small HDL level. Conclusion: E4 allele can be associated with PD as an eligible risk factor, the E3/E3 could be a risk-reducing factor for PD. Patients with PD not only had lower LDL and HDL levels but also they have higher atherogenic LDL and HDL subfractions. Also, E3/E3 genotype carriers had convenient but ApoE4 carriers had atherogenic plasma cholesterol levels and subfractions.
- 10 June 2018
- Published by Taylor & Francis in Nordic Journal of Psychiatry
- Vol. 72 (7) , 477-483
Association between apolipoprotein E genotypes and panic disorder in Turkish population
Aim: In this study, we aimed to investigate possible interactions among the apolipoprotein E (ApoE) and panic disorder (PD), taking into account serum cholesterol levels and subfractions. Methods: ApoE genotyping was performed by real-time polymerase chain reaction in DNA samples of PD patient group (n = 45) and healthy control group (n = 50). The serum lipid levels, low-density lipoprotein (LDL), and high-density lipoprotein (HDL) subfraction analysis were examined. Results: There was a significant difference of ApoE genotypes in patient and control groups. The E3/E3 genotypes lower whereas E4 allele carriers were significantly higher in PD group ApoE4allele carriers had 3.2-fold higher risk of PD. PD group had significantly lower LDL and HDL levels. In spite of the decreased levels of total LDL, antiatherogenic large LDL subgroup was significantly lower in a patient with PD. Antiatherogenic large HDL and Intermediate HDL levels were lower, while atherogenic small HDL subfraction was significantly higher in PD group. Furthermore, Apo E3/E3 genotype carriers had significantly higher large LDL, HDL, large HDL, intermediate HDL level, and also had highest HDL between all the groups. ApoE4 allele carriers while they had highest atherogenic small HDL level. Conclusion: E4 allele can be associated with PD as an eligible risk factor, the E3/E3 could be a risk-reducing factor for PD. Patients with PD not only had lower LDL and HDL levels but also they have higher atherogenic LDL and HDL subfractions. Also, E3/E3 genotype carriers had convenient but ApoE4 carriers had atherogenic plasma cholesterol levels and subfractions.
- 1 May 2018
- Published by Elsevier in Psychiatry Research
- Vol. 263, 125-129
Objective measures of sleep in fibromyalgia syndrome: Relationship to clinical, psychiatric, and immunological variables
- 1 May 2018
- Published by Elsevier in Psychiatry Research
- Vol. 263, 125-129
Objective measures of sleep in fibromyalgia syndrome: Relationship to clinical, psychiatric, and immunological variables
- 15 June 2017
- Published by Physicians Postgraduate Press, Inc in The Primary Care Companion For CNS Disorders
- Vol. 19 (3)
A Case of Fluoxetine-Induced Lower Extremity Ecchymosis
Ms A presented to a dermatology clinic and reported ecchymosis on her legs. She recently started taking fluoxetine for depression. Could fluoxetine be the culprit? Read this case report to find out.
- 15 June 2017
- Published by Physicians Postgraduate Press, Inc in The Primary Care Companion For CNS Disorders
- Vol. 19 (3)
A Case of Fluoxetine-Induced Lower Extremity Ecchymosis
Ms A presented to a dermatology clinic and reported ecchymosis on her legs. She recently started taking fluoxetine for depression. Could fluoxetine be the culprit? Read this case report to find out.
- 21 January 2015
- Vol. 29 (1) , 51-4
Paraoxonase1 192 (PON1 192) gene polymorphism and serum paraoxonase activity in panic disorder patients.
Reactive oxygen species (ROS) are involved in the development of certain neuropsychiatric disorders. Paraoxonase 1 (PON1) activity has been suggested to be adversely related to oxidative stress in plasma. The purpose of the present study was to demonstrate the relationship between serum PON1 activity and PON1 192 polymorphism in panic disorder (PD). Fourty-two patients with PD and 46 healthy controls were included in this study. PON1 192 genotypes were determined by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) analysis. PON1 activity was measured by spectrophotometric assay of p-nitrophenol production following the addition of paraoxon. PON1 192 AA genotype and A allele in PD were significantly higher than in the control group, whereas the B allele was found to be significantly higher in the control group. Patients with panic disorder have lower PON1 activity than the control group. The PON1 192 AA genotype may increase the risk of PD depending on lipid peroxidation.
- 21 January 2015
- Vol. 29 (1) , 51-4
Paraoxonase1 192 (PON1 192) gene polymorphism and serum paraoxonase activity in panic disorder patients.
Reactive oxygen species (ROS) are involved in the development of certain neuropsychiatric disorders. Paraoxonase 1 (PON1) activity has been suggested to be adversely related to oxidative stress in plasma. The purpose of the present study was to demonstrate the relationship between serum PON1 activity and PON1 192 polymorphism in panic disorder (PD). Fourty-two patients with PD and 46 healthy controls were included in this study. PON1 192 genotypes were determined by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) analysis. PON1 activity was measured by spectrophotometric assay of p-nitrophenol production following the addition of paraoxon. PON1 192 AA genotype and A allele in PD were significantly higher than in the control group, whereas the B allele was found to be significantly higher in the control group. Patients with panic disorder have lower PON1 activity than the control group. The PON1 192 AA genotype may increase the risk of PD depending on lipid peroxidation.
- 6 September 2014
- Vol. 28 (5) , 885-9
The relationship between ACE polymorphism and panic disorder.
The angiotensin converting enzyme (ACE) gene, which has been found to have an insertion and deletion polymorphism (I/D), is of increasing interest in etiology and treatment of various psychiatric disorders such as panic disorder. The present study aimed to investigate the relationship between ACE polymorphism and panic disorder. In this study, 43 patients diagnosed with panic disorder at the Erenköy Mental and Neurological Diseases Training and Research Hospital, Istanbul and 41 healthy controls were enrolled. The ACE gene insertion/deletion polymorphism of exon 16 was evaluated using the polymerase chain reaction method. There was a significant association between I/D genotype and panic disorder (p=0.003). However, the frequency of the I allele was found to be significantly higher in patients compared to controls (p=0.002). In addition, we recognized a significant association between I/D polymorphism and respiratory-type panic disorder in patients. Carriers of the D allele also had an increased risk of respiratory type panic disorder patients (p=0.034). Moreover, the result of Spearman correlation analysis showed an association with ACE D allele and severity of panic disorder (p<0.001). We suggest that the I/D polymorphism of the ACE gene is associated with panic disorder and particularly respiratory-type panic disorder in patients. The I/D polymorphism of the ACE gene seems to influence therapeutic outcome in patients suffering from panic disorder. Our results indicate that ACE D allele is associated with the severity of panic disorder.
- 6 September 2014
- Vol. 28 (5) , 885-9
The relationship between ACE polymorphism and panic disorder.
The angiotensin converting enzyme (ACE) gene, which has been found to have an insertion and deletion polymorphism (I/D), is of increasing interest in etiology and treatment of various psychiatric disorders such as panic disorder. The present study aimed to investigate the relationship between ACE polymorphism and panic disorder. In this study, 43 patients diagnosed with panic disorder at the Erenköy Mental and Neurological Diseases Training and Research Hospital, Istanbul and 41 healthy controls were enrolled. The ACE gene insertion/deletion polymorphism of exon 16 was evaluated using the polymerase chain reaction method. There was a significant association between I/D genotype and panic disorder (p=0.003). However, the frequency of the I allele was found to be significantly higher in patients compared to controls (p=0.002). In addition, we recognized a significant association between I/D polymorphism and respiratory-type panic disorder in patients. Carriers of the D allele also had an increased risk of respiratory type panic disorder patients (p=0.034). Moreover, the result of Spearman correlation analysis showed an association with ACE D allele and severity of panic disorder (p<0.001). We suggest that the I/D polymorphism of the ACE gene is associated with panic disorder and particularly respiratory-type panic disorder in patients. The I/D polymorphism of the ACE gene seems to influence therapeutic outcome in patients suffering from panic disorder. Our results indicate that ACE D allele is associated with the severity of panic disorder.